Coffin Robert
Director at REPL
- Sold, on record
- $21.1M
- Dollars the filings state
- Form 4 sales
- 14
- Latest May 16, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- REPLReplimune Group, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale REPLUnusualJul 9 2020
Sold 169,750 shares at $22.13 ($3.8M)
Coffin Robert, President & Chief R&D Officer
Sold 7.7% of holdings ($48.6M position)2M shares left4.7x usual sizeFiling
- 2 Form 4 sale REPLUnusualDec 22 +166 days
Sold 220,000 shares at $40.04 ($8.8M)
Coffin Robert, President & Chief R&D Officer
Sold 10.9% of holdings ($81M position)1.8M shares left4.5x usual sizeFiling
- 3 Form 4 sale REPLPlan not statedJan 22 +31 days
Sold 60,000 shares at $44.43 ($2.7M)
Coffin Robert, President & Chief R&D Officer
Sold 3.3% of holdings ($80.2M position)1.7M shares left1.2x usual sizeFiling
- 4 Form 4 sale REPLPlan not statedJun 29 +158 days
Sold 37,489 shares at $40.05 ($1.5M)
Coffin Robert, President & Chief R&D Officer
Sold 2.1% of holdings ($72.9M position)1.8M shares left0.8x usual sizeFiling
- 5 Form 4 sale REPLPlan not statedJul 2 +3 days
Sold 7,810 shares at $40.04 ($313k)
Coffin Robert, President & Chief R&D Officer
Sold 0.4% of holdings ($71.4M position)1.8M shares left0.2x usual sizeFiling
- 6 Form 4 sale REPLPlan not statedMay 16 +318 days
Sold 5,737 shares at $14.59 ($84k)
Coffin Robert, President & Chief R&D Officer
Sold 0.3% of holdings ($26.3M position)1.8M shares left0.1x usual sizeFiling
- 7 Form 4 sale REPLNo planMay 16 +365 days
Sold 7,861 shares at $18.05 ($142k)
Coffin Robert, President & Chief R&D Officer
No 10b5-1 planSold 0.4% of holdings ($33.2M position)1.8M shares left1x usual sizeFiling
- 8 Form 4 sale REPLNo planMay 16 +366 days
Sold 11,464 shares at $6.47 ($74k)
Coffin Robert, Director
No 10b5-1 planSold 0.6% of holdings ($11.9M position)1.8M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | REPL | Director | Form 4 sale | 11,464 | $74k | 0.6% | No plan | SEC |
| May 16, 2023 | REPL | President & Chief R&D Officer | Form 4 sale | 7,861 | $142k | 0.4% | No plan | SEC |
| May 16, 2022 | REPL | President & Chief R&D Officer | Form 4 sale | 5,737 | $84k | 0.3% | Plan not stated | SEC |
| Jul 2, 2021 | REPL | President & Chief R&D Officer | Form 4 sale | 7,810 | $313k | 0.4% | Plan not stated | SEC |
| Jun 29, 2021 | REPL | President & Chief R&D Officer | Form 4 sale | 37,489 | $1.5M | 2.1% | Plan not stated | SEC |
| Jan 22, 2021 | REPL | President & Chief R&D Officer | Form 4 sale | 60,000 | $2.7M | 3.3% | Plan not stated | SEC |
| Dec 22, 2020 | REPL | President & Chief R&D Officer | Form 4 sale | 220,000 | $8.8M | 10.9% | Unusual | SEC |
| Jul 9, 2020 | REPL | President & Chief R&D Officer | Form 4 sale | 169,750 | $3.8M | 7.7% | Unusual | SEC |
| Feb 20, 2020 | REPL | Pres & Chief Res & Dev Officer | Form 4 sale | 24,250 | $413k | 1.1% | Plan not stated | SEC |
| Feb 12, 2020 | REPL | Pres & Chief Res & Dev Officer | Form 4 sale | 48,500 | $826k | 2.1% | Plan not stated | SEC |
| Nov 6, 2019 | REPL | President and CEO | Form 4 sale | 48,500 | $825k | 2.1% | Plan not stated | SEC |
| Nov 4, 2019 | REPL | President and CEO | Form 4 sale | 48,500 | $826k | 2.1% | Plan not stated | SEC |
| Oct 31, 2019 | REPL | President and CEO | Form 4 sale | 24,250 | $412k | 1.0% | Plan not stated | SEC |
| Sep 23, 2019 | REPL | President and CEO | Form 4 sale | 24,250 | $413k | 1.0% | Plan not stated | SEC |